Douglas STEWART

Cертификация

Личные данные

Об эксперте / Обо мне

Cambridge Epigenetix aims to change the way medicine is practised by reducing several routine and important diagnostic screening tests to detect cancer and other common diseases to a simple blood draw using the power of the 5-hydroxymethylcytosine (5hmC) epigenetic modification. Doug Stewart has over 20 years of experience in clinical research, project, change and process management.